Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Auditory Sensory Memory Processing

NCT02426983 is registered in ClinicalTrials.gov with University of Ottawa as lead sponsor.

NCT NCT02426983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02426983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Auditory Sensory Memory Processing
Lead sponsor
University of Ottawa
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2015
Completion date
April 30, 2016
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia